226
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, mesomorphic behaviour and photo-luminescent property of new mesogens containing 1,3,4-oxadiazole fluorophore

, , &
Pages 1521-1527 | Received 10 Jun 2010, Accepted 03 Sep 2010, Published online: 10 Dec 2010
 

Abstract

A series of 1,3,4-oxadiazole derivatives, namely cholesteryl 4-(4-(5-(4-(alkoxy)phenyl)-1,3,4-oxadiazol-2-yl)phenylethynyl)benzoate (Ch-OXD- n , n = 6, 8, 10) and methyl 4-(4-(5-(4-(alkoxy)phenyl)-1,3,4-oxadiazol-2-yl)phenylethynyl)benzoate (Me-OXD- n , n = 6, 8, 10) were synthesised and characterised by means of 1H NMR, 13C NMR, MS and HRMS. The phase behaviours of these two series of compounds have been investigated by polarising microscopic and calorimetric studies. All compounds Ch-OXD- n exhibited a cholesteric mesophase with wide mesomorphic temperature range, while the compounds Me-OXD- n displayed nematic and/or smectic A mesophases with relatively narrow temperature ranges. Both Ch-OXD- 8 and Me-OXD- 8 in chloroform individually exhibited an intense absorption band (λmax = 330 nm) and a strong blue fluorescence emission (λmax = 404 nm) with good photoluminescence quantum yields.

Acknowledgements

This work was financially supported by grants from Open Project of State Key Laboratory of Supramolecular Structure and Materials (SKLSSM200908) and the National Natural Science Foundation of China (No.20772064).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.